当前位置: 首页 > 期刊 > 《中国当代医药》 > 2012年第12期
编号:12220370
G蛋白信号调节因子在心血管系统中的作用(3)
http://www.100md.com 2012年4月25日 《中国当代医药》 2012年第12期
     [8]Ooe A,Kato K,Noguchi S. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers[J]. Breast Cancer Res Treat,2007,101(3):305-315.

    [9]Rogers JH, Tsirka A, Kovacs A, et al. RGS4 reduces contractile dysfunction and hypertrophic gene induction in G_q overexpressing mice[J]. J Mol Cell Cardiol,2001,33:209-218.

    [10]D’Angelo DD, Sakata Y, Lorenz JN, et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice[J]. Proc Natl Acad Sci USA,1997,94(15):8121-8126.

    [11] Adams JW, Sakata Y, Davis MG, et al. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure[J]. Proc Natl Acad Sci USA,1998,95(17):10140-10145.

    [12]Bondjers C, Kalen M, Hellstrom M,et al. Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells[J].Am J Pathol,2003,162(3):721-729.

    [13]Cho H, Kozasa T, Bondjers C,et al. Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation[J]. Faseb J,2003,17(3):440-442.

    (收稿日期:2012-02-24本文编辑:马 双), 百拇医药(史潍华)
上一页1 2 3